Richard A Klein

Title: The Innovations of Richard A. Klein

Introduction

Richard A. Klein is a notable inventor based in Edmonds, Washington, with a significant contribution to the field of vascular medicine. He holds a total of eight patents, showcasing his dedication to advancing therapeutic methods for vascular health. His work primarily focuses on innovative solutions to inhibit vascular complications following trauma or disease.

Latest Patents

Among his latest patents, Klein has developed methods for inhibiting stenosis or restenosis in vascular trauma. One of his key inventions involves administering a therapeutically effective dosage of a cytostatic agent and/or cytoskeletal inhibitor to biologically stent the traumatized vessel. Additionally, he has created methods to inhibit or reduce vascular remodeling following trauma, which includes pharmaceutical compositions and kits that utilize these therapeutic agents. Another significant patent addresses the use of a therapeutic conjugate containing a vascular smooth muscle binding protein, which specifically targets vascular smooth muscle cells to inhibit their contraction, thereby facilitating vascular dilation and fixation.

Career Highlights

Klein has had a distinguished career, working with companies such as Neorx Corporation and Noerx Corporation. His experience in these organizations has allowed him to refine his expertise in developing innovative therapeutic solutions for vascular health.

Collaborations

Throughout his career, Klein has collaborated with notable professionals in the field, including Lawrence L. Kunz and John M. Reno. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Richard A. Klein's contributions to vascular medicine through his innovative patents demonstrate his commitment to improving patient outcomes. His work continues to influence the field and offers promising solutions for vascular health challenges.